New Zealand markets closed

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
48.77+0.97 (+2.03%)
At close: 04:00PM EST
48.50 -0.27 (-0.55%)
After hours: 08:00PM EST
Show:
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
46,444,000
45,389,000
39,175,000
37,369,000
Cost of revenue
14,236,000
13,695,000
12,255,000
12,159,000
Gross profit
32,208,000
31,694,000
26,920,000
25,210,000
Operating expenses
Research development
6,728,000
6,706,000
5,692,000
5,530,000
Selling general and administrative
10,692,000
10,492,000
9,555,000
9,391,000
Total operating expenses
21,816,000
19,813,000
17,773,000
17,320,000
Operating income or loss
10,392,000
11,881,000
9,147,000
7,890,000
Interest expense
1,313,000
472,000
403,000
434,000
Total other income/expenses net
-2,517,000
-1,228,000
-1,016,000
6,223,000
Income before tax
7,153,000
10,422,000
7,798,000
13,778,000
Income tax expense
1,602,000
2,006,000
1,558,000
1,807,000
Income from continuing operations
5,436,000
8,484,000
6,279,000
12,330,000
Net income
5,400,000
8,371,000
6,223,000
12,294,000
Net income available to common shareholders
5,400,000
8,371,000
6,223,000
12,294,000
Basic EPS
3.62
3.35
2.48
4.91
Diluted EPS
3.61
3.33
2.48
4.88
Basic average shares
2,503,500
2,503,800
2,505,000
2,507,200
Diluted average shares
2,507,720
2,513,800
2,515,800
2,520,200